Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Insulin-like growth factor I as a cardiac hormone.J Mol Cell Cardiol. 1999; 31: 2049-2061
- Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction.J Am Coll Cardiol. 2001; 38: 26-32
- Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins.J Clin Endocrinol Metab. 1996; 81: 1791-1797
- A polymorphism in the gene for IGF-I.Diabetes. 2001; 50: 637-642
- A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.Clin Endocrinol. 2004; 61: 195-203
- Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study).Am J Cardiol. 2004; 94: 384-386
- Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart.Circ Res. 1999; 84: 1007-1019
The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; Organization for Scientific Research, The Netherlands Organization for Health Research and Development, the Research Institute for Diseases in the Elderly, the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, and the European Commission (DG XII), The Hague; the Municipality of Rotterdam, Rotterdam; and the Centre for Medical Systems Biology, Leiden, The Netherlands.